Carisma Therapeutics Inc (NASDAQ:CARM)
| 6.06 Delayed Data As of Jun 09 |  -0.02 / -0.33%Today’s Change | 2.75 Today|||52-Week Range 19.30 | -50.29% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -33.5M | 1.9M | -29.0M | -33.7M | |
| Depreciation | 366.0K | 178.0K | 285.0K | 208.0K | ||
| Total Other Cash Flow | -467.0K | 3.0M | 10.4M | 10.1M | ||
| Funds From Operations | -33.6M | 5.1M | -18.4M | -23.4M | ||
| Funds From/For Other Operating Expenses | 976.0K | 2.5M | -611.0K | -578.0K | ||
| Net Cash Flow - Operating Activities | -34.5M | 2.6M | -17.8M | -22.8M | ||
| Investing | Capital Expenditures | -287.0K | 0.00 | -- | -2.0K | |
| Fixed Asset Disposal | -- | 461.0K | 98.0K | 0.00 | ||
| Net Cash Flow Investing | -287.0K | 461.0K | 98.0K | -2.0K | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 5.0M | 0.00 | 0.00 | 0.00 | ||
| Long Term Debt Reduction | -877.0K | -14.1M | 0.00 | 0.00 | ||
| Net Proceeds Stock Sale | 12.7M | 304.0K | 7.0M | 58.6M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 16.8M | -13.8M | 7.0M | 58.6M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -18.0M | -10.7M | -10.7M | 35.8M | ||
